Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06034496
Other study ID # STUDY00003572
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 12, 2023
Est. completion date July 2025

Study information

Verified date November 2023
Source Tufts University
Contact Kana Okano, Ph.D.
Phone (617) 627-1059
Email kana.okano@tufts.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to quantify the effects of 20 sessions of Cranial Electrotherapy Stimulation (CES) on measures of acute stress responses in Soldiers. The main question it aims to answer is how 20 sessions of CES will affect Soldiers' biochemical (salivary alpha amylase and cortisol), physiological (e.g., heart rate, heart rate variability, respiration rate), emotional (state anxiety), and behavioral (i.e., cognitive task performance) responses. - On Day 1, participants will complete a baseline measure assessing their biochemical, physiological, emotional, and behavioral responses to a stressful lethal force decision making task. - In the next four to six weeks, participants will complete 20 CES sessions. - Within five days of completing the 20 CES sessions, participants will complete a follow-up measure assessing their biochemical, physiological, emotional, and behavioral responses to the same stressful lethal force decision making task they completed on Day 1. Researchers will compare the Active CES group to the Sham CES group to see how 20 sessions of Active CES will affect the participants responses to their biochemical, physiological, emotional and behavioral responses relative to the Sham CES group.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date July 2025
Est. primary completion date July 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - 18-40 years of age (17-40 if emancipated minor) - Can sit and stand freely. - Have not used or experienced CES administration in the past. - Agree to have their data stored in a repository (database) for future use. Exclusion Criteria: - Use of prescription medications, other than oral contraceptives - Women only: 1. Pregnant or plan to become pregnant during the study 2. Nursing - History of: 1. A neurological or psychological disorder (such as depression, anxiety disorders, migraines, cluster headaches, seizures, Post-traumatic stress disorder (PTSD) or panic attacks). 2. Cardiac disease (including arrhythmia or fast or skipped heart beats). 3. Implanted medical devices, such as pacemakers. 4. Hypertension. 5. Insomnia 6. Head injury (including neurosurgery, concussion, TBI, skull fracture, hematoma) 7. Illness that caused brain injury 8. Any other brain-related condition (such as traumatic brain injury) 9. Metal in the head (outside of mouth, such as shrapnel, surgical clips, or fragments from welding or metalwork) 10. Implanted medical device (e.g., pacemaker, insulin pump)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active CES
Active CES group will receive a minimum of 250µA and up to 500µA depending on thresholding, once daily for 20 days (over the course of 4~6 weeks), 20 minutes per day.
Sham CES
Sham CES group will be identical to Active CES group with the exception of the device not administering any electrical current

Locations

Country Name City State
United States Tufts University Medford Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Tufts University United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in heart rate during stressful lethal force decision making task heart rate will be measured in beats per minute. Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Primary Change from baseline in respiration rate during stressful lethal force decision making task respiration rate will be measured in breaths per minute. Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Primary Change from baseline in heart rate variability during stressful lethal force decision making task Heart rate variability will be measured in RMSSD. Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Primary Change over time in alpha amylase during stressful lethal force decision making task Alpha amylase (IU) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions. Baseline and follow-up session after 20 CES completed within 4-6weeks
Primary Change over time in cortisol during stressful lethal force decision making task Cortisol (ng/dL) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions. Baseline and follow-up session after 20 CES completed within 4-6weeks
Primary Change over time in State Trait Anxiety Inventory (STAI) scores at each session (including CES sessions) from baseline to follow-up STAI assesses both state and trait anxiety separately with each scale ranging from 20 to 80, with higher scores correlating with greater anxiety. At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES
Primary Change from baseline in recognition memory Recognition memory of previously learned targets while ignoring visually similar distractor objects will be measured and evaluated with d prime scores. Higher d prime scores correlate with more accurate responses. Baseline and follow-up session after 20 CES completed within 4-6weeks
Primary Change from baseline in spatial orientation Spatial orientation task will involve pointing towards a series of distant (out of visible range) landmarks in the virtual environment and estimating distance to those landmarks. Spatial orientation will be calculated using mean absolute angular error. Larger numbers correlate with higher error. Baseline and follow-up session after 20 CES completed within 4-6weeks
Primary Change from baseline in decision making accuracy Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making accuracy will be calculated using d prime. Higher d prime correlates with better accuracy. Baseline and follow-up session after 20 CES completed within 4-6weeks
Primary Change from baseline in decision making reaction time Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making reaction time to shoot at threatening targets will be measured in milliseconds. Baseline and follow-up session after 20 CES completed within 4-6weeks
See also
  Status Clinical Trial Phase
Completed NCT05760482 - Evaluation of the Relationship Between Bruxism and Tryptophan Metabolites N/A
Recruiting NCT04368416 - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Completed NCT01190774 - Anxiety Assessment Intervention in Dental Patients Phase 2/Phase 3
Not yet recruiting NCT06418269 - The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes N/A
Recruiting NCT06215456 - Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography N/A
Completed NCT06114524 - Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation N/A
Completed NCT05316415 - The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy N/A
Recruiting NCT05433636 - Mindful Waiting Room N/A
Recruiting NCT06187090 - The Supplementation Therapy in Autism and Response to Treatment Study N/A
Completed NCT05499767 - HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults N/A
Not yet recruiting NCT03671317 - Medical Clowns for Pediatric Blood Draw N/A
Terminated NCT03227562 - Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety? Phase 3
Completed NCT04040036 - Effects of Virtual Reality on Pain, Fear and Anxiety During Blood Draw in Children Aged 5-12 Years Old N/A
Completed NCT04568551 - COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor
Recruiting NCT06190184 - Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions N/A
Completed NCT04601545 - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method N/A
Completed NCT06223412 - Visual Based Program and Climate Change N/A
Recruiting NCT04356638 - a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients Phase 3
Completed NCT03977948 - Qualitative and Systemic Assessment of a Nurse Intervention an Inpatient Child and His or Her Parents
Completed NCT06187233 - The Effects of Binaural Beats on Pain, Anxiety, and Procedure Tolerance in Patients Undergoing Colonoscopy Without Sedation N/A